A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse

Kidney International

Volumn 60, Issue 2, 2001, Pages 505-512

  Landau, Daniel ^a,b,c,d   Segev, Yael ^a,b,c,d   Afargan, Michel ^a,b,c,d   Silbergeld, Aviva ^a,b,c,d   Katchko, Leonid ^a,b,c,d   Podshyvalov, Andrey ^a,b,c,d   Phillip, Moshe ^a,b,c,d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Peptor Ltd   (Israel)

Author keywords

Albuminuria; Diabetes; Growth hormone; Insulin like growth factor I; PTR 3173; Renal hypertrophy

Indexed keywords

GROWTH HORMONE; PTR 3173; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; GROWTH HORMONE BLOOD LEVEL; KIDNEY HYPERTROPHY; KIDNEY MASS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA;

EID: 0034912214     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.060002505.x     Document Type: Article

References (44)

1. Prognosis of diabetics with diabetes onset before age of thirty-one
2. Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics
3. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients
4. Early function and morphological changes in diabetic nephropathy
5. Insulin-like growth factors, their binding proteins and receptors as growth regulators in normal physiology and pathological states
6. Expression of insulin-like growth factor binding proteins in the rat kidney: Effects of long-term diabetes
7. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes
8. Renal growth hormone gene expression: Relationship to renal insulin-like growth factor system
9. Changes in the growth hormone-IGF-I axis in nonobese diabetic mice
10. Growth hormone receptor antagonism prevents early renal changes in the non-obese diabetic (NOD) mouse
11. Somatostatin
12. Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients
13. Novel long acting somatostatin analog with endocrine selectivity: Potent suppression of growth hormone but not of insulin
14. Regulation of immunoreactive growth hormone secretion in male rats
15. Radioimmunoassays for IGFs and IGFBPs
16. Studies of GH secretion in mice by a homologous radioimmunoassay for mouse GH
17. Stereological methods
18. Morphometric analysis of effects of angiotensin II on glomerular structure in rats
19. Determination with glucose oxidase and peroxidase
20. Abnormal growth hormone response to ingestion of glucose in juvenile diabetes
21. Integrated concentration of growth hormone in juvenile-onset diabetes
22. Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone: Studies in transgenic mice
23. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice
24. A growth hormone antagonist protects mice against streptozotocin induced glomerulosclerosis even in the presence of elevated levels of glucose and glycated hemoglobin
25. Inhibition of diabetic nephropathy by a GH antagonist: A molecular analysis
26. Breeding of a non-obese diabetic strain of mice
27. Animal models of spontaneous diabetic kidney disease
28. Transfer of autoimmune diabetes mellitus with splenocytes from the non-obese diabetic (NOD) mice
29. Glomerular lesions in nonobese diabetic mouse: Before and after the onset of hyperglycemia
30. Renal hypertrophy in hyperglycemic non-obese diabetic mice is associated with renal accumulation of insulin-like growth factor (IGF) I
31. Effect of lanreotide, a somatostatin analogue, on diabetic renal hypertrophy, kidney and serum IGF-I and IGF binding proteins
32. Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes
33. Effect of long-acting somatostatin analog (Somatulin) on renal hyperfiltration in patients with IDDM
34. Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients
35. Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional states in rat tissues
36. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes
37. Molecular biology of somatostatin receptors
38. Somatostatin inhibits insulin and glucagon secretion via two receptor subtypes: An in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice
39. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat
40. Human kidney as target for somatostatin: High affinity receptors in tubules and vasa recta
41. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney
42. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth
43. Characterization of somatostatin receptors in the rat adrenal glomerulosa zone
44. Effects of somatostatin on cultured human mesangial cells